InsidersTradesSigma
Track the 康龙化成 stock price and the full management transaction log of the company, a listed equity based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 康龙化成 has logged 5 insider filings. Market capitalisation: €68.4bn. The latest transaction was filed on 19 September 2023 (Sale). Among the most active insiders: 楼小强. All data is accessible without an account.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€5m
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 康龙化成 Buy (bullish), based on 11 analysts. Average price target: CN¥37.73.
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,678 of 28,803 companies
47.5
score / 100
Value37
Quality58
FCF yld0.8%
Earn yld2.4%
EV/EBITDA22.9x
ROE10.0%
Gross mgn35%
Net mgn12%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 September 2023
Declarations5 total
5 of 5 declarations
About 康龙化成
康龙化成 is a company specializing in the healthcare and pharmaceutical sector, providing research and development services. It is listed on the XSHE market.